Xiulan Zhang Selected Research

Angle-Closure Glaucoma (Glaucoma, Angle Closure)

1/2022	Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study).
12/2020	AGE challenge: Angle Closure Glaucoma Evaluation in Anterior Segment Optical Coherence Tomography.
12/2018	Inflammatory cytokine profiles in eyes with primary angle-closure glaucoma.
1/2018	Anterior Choroidal Thickness Increased in Primary Open-Angle Glaucoma and Primary Angle-Closure Disease Eyes Evidenced by Ultrasound Biomicroscopy and SS-OCT.
5/2016	Chemokine (C-C motif) ligand 2 and chemokine (C-C motif) ligand 7 in angle-closure glaucoma.
1/2016	Re: Narayanaswamy et al.: Argon laser peripheral iridoplasty for primary angle-closure glaucoma: a randomized controlled trial (Ophthalmology 2016;123:514-21).
1/2016	Vascular Endothelial Growth Factor is Increased in Aqueous Humor of Acute Primary Angle-Closure Eyes.
4/2014	Changes in choroidal thickness after trabeculectomy in primary angle closure glaucoma.
10/2011	Sustained elevation of extracellular ATP in aqueous humor from humans with primary chronic angle-closure glaucoma.
11/2007	Acute increase of intraocular pressure releases ATP into the anterior chamber.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiulan Zhang Research Topics

Disease

29	Glaucoma 03/2022 - 06/2007
11	Cataract (Cataracts) 01/2022 - 10/2011
11	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 01/2022 - 06/2007
11	Open-Angle Glaucoma (Glaucoma, Open Angle) 12/2020 - 01/2013
9	Neoplasms (Cancer) 11/2021 - 02/2003
7	Ganglion Cysts (Ganglion) 01/2022 - 06/2005
6	Neovascular Glaucoma 01/2016 - 06/2013
4	Ocular Hypertension (Glaucoma, Suspect) 10/2021 - 02/2017
4	Inflammation (Inflammations) 01/2021 - 02/2014
4	Optic Nerve Diseases (Optic Neuropathy) 12/2020 - 05/2016
3	Pain (Aches) 01/2020 - 11/2007
3	Neoplasm Metastasis (Metastasis) 05/2017 - 05/2014
3	Breast Neoplasms (Breast Cancer) 05/2017 - 01/2010
2	Myopia 01/2022 - 12/2021
2	Neuroinflammatory Diseases 01/2021 - 02/2017
2	Hypoxia (Hypoxemia) 06/2016 - 01/2016
2	Nasopharyngeal Carcinoma 05/2016 - 10/2015
2	Hypertension (High Blood Pressure) 05/2016 - 01/2014
2	Ischemia 01/2016 - 11/2010
2	Macular Degeneration (Age-Related Maculopathy) 06/2014 - 01/2014
2	Hyphema 01/2014 - 01/2013
1	Genomic Instability 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 11/2021
1	Wounds and Injuries (Trauma) 10/2021
1	Blindness (Hysterical Blindness) 12/2020
1	Vision Disorders (Hemeralopia) 12/2020
1	Erythema 01/2020
1	Macular Edema 09/2018
1	Burns 11/2017
1	Hyperplasia 11/2017
1	Necrosis 02/2017
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2017
1	Disease Progression 01/2017
1	Hepatitis B 05/2016
1	Bacterial Infections (Bacterial Infection) 01/2016
1	Hyperopia (Hypermetropia) 11/2015
1	Cysts 09/2014
1	Respiratory Tract Infections (Respiratory Tract Infection) 06/2014
1	Hepatolenticular Degeneration (Wilson's Disease) 03/2014

Drug/Important Bio-Agent (IBA)

11	Retinaldehyde (Retinal)IBA 01/2022 - 11/2010
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018 - 06/2013
6	Adenosine Triphosphate (ATP)IBA 05/2015 - 11/2007
4	CytokinesIBA 01/2021 - 02/2014
4	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2017
4	Proteins (Proteins, Gene)FDA Link 05/2017 - 01/2010
4	Ranibizumab (Lucentis)FDA Link 01/2016 - 01/2014
4	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateIBA 09/2010 - 06/2005
3	ORALIT (ORS)IBA 01/2022 - 01/2013
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2020
3	Neuroprotective AgentsIBA 01/2021 - 09/2010
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2013
3	Bevacizumab (Avastin)FDA Link 01/2016 - 06/2013
3	Adenosine (Adenocard)FDA LinkGeneric 09/2010 - 07/2006
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 10/2021 - 09/2014
2	cytoplasmic protein A (PACD)IBA 01/2018 - 11/2015
2	ArgonIBA 01/2016 - 01/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 06/2014
2	CollagenIBA 09/2013 - 09/2012
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 09/2010 - 08/2006
1	Long Noncoding RNAIBA 01/2022
1	Antimalarials (Antimalarial Agents)IBA 11/2021
1	Mefloquine (Lariam)FDA LinkGeneric 11/2021
1	acceleratory factor from growth hormone (AcG)IBA 12/2020
1	Small Nucleolar RNA (snoRNA)IBA 01/2020
1	MMEIBA 09/2018
1	AlkaliesIBA 11/2017
1	oridoninIBA 05/2017
1	p38 Mitogen-Activated Protein KinasesIBA 02/2017
1	CC ChemokinesIBA 05/2016
1	LigandsIBA 05/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2016
1	Biological ProductsIBA 01/2016
1	Placenta Growth FactorIBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	PorphyrinsIBA 10/2015
1	pigment epithelium-derived factorIBA 07/2015
1	CD39 antigenIBA 05/2015
1	Caveolin 1IBA 08/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2014
1	CateninsIBA 05/2014
1	protoapigenoneIBA 05/2014
1	Cadherins (E-Cadherin)IBA 05/2014
1	matrigelIBA 05/2014
1	2- (1- hydroxy- 4- oxocyclohexa- 2,5- dienyl)pyran- 4- oneIBA 05/2014
1	CopperIBA 03/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2014

Therapy/Procedure

16	Trabeculectomy (Trabeculoplasty) 03/2022 - 06/2007
5	Lasers (Laser) 10/2021 - 01/2013
5	Therapeutics 01/2021 - 09/2012
4	Intravitreal Injections 01/2016 - 06/2013
3	Filtering Surgery 10/2021 - 05/2016
1	Iridectomy 01/2022
1	Aftercare (After-Treatment) 01/2020
1	Pain Management 01/2019
1	Cannula 02/2017
1	Vitrectomy 01/2017
1	Drug Therapy (Chemotherapy) 05/2016
1	Radiotherapy 05/2016
1	Sutures (Suture) 03/2014